Press Releases
FDA Announces Dr. Amy Abernethy as Principal Deputy Commissioner of Food and Drugs
Friends of Cancer Research Applauds this Appointment and Thanks Dr. Rachel Sherman for Her Incredible Service December 17, 2018 – Washington, DC – Today, the
Friends of Cancer Research and ASCO Applaud NCI's Expansion of Clinical Trial Eligibility Criteria
WASHINGTON, DC – The American Society of Clinical Oncology, Inc. (ASCO) and Friends of Cancer Research (Friends) applaud the National Cancer Institute’s (NCI) recent revision
Friends of Cancer Research Releases Results of TMB Harmonization Project – Phase I
Results to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting November 6, 2018 – Washington, DC – Friends of Cancer
Making Objective Drug Evidence Revisions for New Labeling Act Introduced to Senate
Senators Hatch and Bennet Introduce Bipartisan Solution to Important Public Health Issue September 28, 2018 – Washington, DC – Friends of Cancer Research (Friends) applauds
Friends of Cancer Research Announces Launch of Phase II TMB Harmonization Project
September 18, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) announced the launch of Phase II of its tumor mutational burden or
Two Cancer Research Organizations Submit Recommendations to FDA Aimed at Reducing Barriers to Clinical Trial Participation
August 9, 2018 – WASHINGTON, D.C. – The American Society of Clinical Oncology, Inc. (ASCO®) and Friends of Cancer Research (Friends) have submitted to the
Friends of Cancer Research Releases Initial Findings of Real-World Evidence Initiative
New Data Supporting Use of Real-World Evidence Presented with Six Data Partners as well as FDA July 10, 2018 – Washington, DC – Today, Friends
New York Times Editorial Ignores Modern Science; Advocates for Policies that Could Hurt Patients
June 11, 2018 – Washington, DC – On Friday, June 8, 2018, The New York Times published an editorial titled “Easier Drug Approval Isn’t Cutting
Friends’ Founder, Ellen Sigal, to Participate in Public Meeting on Oncology Center of Excellence
“Cancer patients cannot afford logistical delays and the OCE was not established to add another layer of bureaucracy.” – Ellen Sigal Washington, DC – March
President Nominates Alex Azar as Next HHS Secretary
WASHINGTON, DC, November 13, 2017 – Today, President Trump nominated Alex Azar to be the next Health and Human Services (HHS) Secretary. As the former